Clinical Trial Update: Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers. [Phase 2]

View source ↗

Summary

Phase 2 safety trial for the RedDress Wound Care System in managing neuropathic diabetic foot ulcers completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Neuropathic Diabetic Foot Ulcer

Drugs mentioned

• RedDress Wound Care System

Snippet

Sponsor: RedDress Ltd. | Conditions: Neuropathic Diabetic Ulcer - Foot | Phase 2 | Status: COMPLETED | Results posted: 2020-11-16